Request for Covid-19 Impact Assessment of this Report
The United States Medical Foods for Inborn Errors of Metabolism market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Medical Foods for Inborn Errors of Metabolism market, reaching US$ million by the year 2028. As for the Europe Medical Foods for Inborn Errors of Metabolism landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Medical Foods for Inborn Errors of Metabolism players cover Nestlé, Abbott, Reckitt Benckiser Group, and Ajinomoto, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Foods for Inborn Errors of Metabolism market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Amino Acid
Glytactin with GMP
Amino Acid-Modified Infant Formula With Iron
Low Protein Food
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Phenylketonuria (PKU)
Maple Syrup Urine Disease (MSUD)
Urea Cycle Disorders
Renal Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Nestlé
Abbott
Reckitt Benckiser Group
Ajinomoto
Solace Nutrition
Primus Pharmaceuticals
BioMarin Pharmaceutical
Danone SA
Galen Limited
PKU-MDMIL
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Foods for Inborn Errors of Metabolism Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Medical Foods for Inborn Errors of Metabolism by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Medical Foods for Inborn Errors of Metabolism by Country/Region, 2017, 2022 & 2028
2.2 Medical Foods for Inborn Errors of Metabolism Segment by Type
2.2.1 Amino Acid
2.2.2 Glytactin with GMP
2.2.3 Amino Acid-Modified Infant Formula With Iron
2.2.4 Low Protein Food
2.2.5 Others
2.3 Medical Foods for Inborn Errors of Metabolism Sales by Type
2.3.1 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2022)
2.3.2 Global Medical Foods for Inborn Errors of Metabolism Revenue and Market Share by Type (2017-2022)
2.3.3 Global Medical Foods for Inborn Errors of Metabolism Sale Price by Type (2017-2022)
2.4 Medical Foods for Inborn Errors of Metabolism Segment by Application
2.4.1 Phenylketonuria (PKU)
2.4.2 Maple Syrup Urine Disease (MSUD)
2.4.3 Urea Cycle Disorders
2.4.4 Renal Disease
2.4.5 Others
2.5 Medical Foods for Inborn Errors of Metabolism Sales by Application
2.5.1 Global Medical Foods for Inborn Errors of Metabolism Sale Market Share by Application (2017-2022)
2.5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue and Market Share by Application (2017-2022)
2.5.3 Global Medical Foods for Inborn Errors of Metabolism Sale Price by Application (2017-2022)
3 Global Medical Foods for Inborn Errors of Metabolism by Company
3.1 Global Medical Foods for Inborn Errors of Metabolism Breakdown Data by Company
3.1.1 Global Medical Foods for Inborn Errors of Metabolism Annual Sales by Company (2020-2022)
3.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Company (2020-2022)
3.2 Global Medical Foods for Inborn Errors of Metabolism Annual Revenue by Company (2020-2022)
3.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Company (2020-2022)
3.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Company (2020-2022)
3.3 Global Medical Foods for Inborn Errors of Metabolism Sale Price by Company
3.4 Key Manufacturers Medical Foods for Inborn Errors of Metabolism Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Foods for Inborn Errors of Metabolism Product Location Distribution
3.4.2 Players Medical Foods for Inborn Errors of Metabolism Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Foods for Inborn Errors of Metabolism by Geographic Region
4.1 World Historic Medical Foods for Inborn Errors of Metabolism Market Size by Geographic Region (2017-2022)
4.1.1 Global Medical Foods for Inborn Errors of Metabolism Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Medical Foods for Inborn Errors of Metabolism Annual Revenue by Geographic Region
4.2 World Historic Medical Foods for Inborn Errors of Metabolism Market Size by Country/Region (2017-2022)
4.2.1 Global Medical Foods for Inborn Errors of Metabolism Annual Sales by Country/Region (2017-2022)
4.2.2 Global Medical Foods for Inborn Errors of Metabolism Annual Revenue by Country/Region
4.3 Americas Medical Foods for Inborn Errors of Metabolism Sales Growth
4.4 APAC Medical Foods for Inborn Errors of Metabolism Sales Growth
4.5 Europe Medical Foods for Inborn Errors of Metabolism Sales Growth
4.6 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Growth
5 Americas
5.1 Americas Medical Foods for Inborn Errors of Metabolism Sales by Country
5.1.1 Americas Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022)
5.1.2 Americas Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022)
5.2 Americas Medical Foods for Inborn Errors of Metabolism Sales by Type
5.3 Americas Medical Foods for Inborn Errors of Metabolism Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Foods for Inborn Errors of Metabolism Sales by Region
6.1.1 APAC Medical Foods for Inborn Errors of Metabolism Sales by Region (2017-2022)
6.1.2 APAC Medical Foods for Inborn Errors of Metabolism Revenue by Region (2017-2022)
6.2 APAC Medical Foods for Inborn Errors of Metabolism Sales by Type
6.3 APAC Medical Foods for Inborn Errors of Metabolism Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Foods for Inborn Errors of Metabolism by Country
7.1.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022)
7.1.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022)
7.2 Europe Medical Foods for Inborn Errors of Metabolism Sales by Type
7.3 Europe Medical Foods for Inborn Errors of Metabolism Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Foods for Inborn Errors of Metabolism by Country
8.1.1 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022)
8.1.2 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022)
8.2 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Type
8.3 Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Foods for Inborn Errors of Metabolism
10.3 Manufacturing Process Analysis of Medical Foods for Inborn Errors of Metabolism
10.4 Industry Chain Structure of Medical Foods for Inborn Errors of Metabolism
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Foods for Inborn Errors of Metabolism Distributors
11.3 Medical Foods for Inborn Errors of Metabolism Customer
12 World Forecast Review for Medical Foods for Inborn Errors of Metabolism by Geographic Region
12.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Region
12.1.1 Global Medical Foods for Inborn Errors of Metabolism Forecast by Region (2023-2028)
12.1.2 Global Medical Foods for Inborn Errors of Metabolism Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Foods for Inborn Errors of Metabolism Forecast by Type
12.7 Global Medical Foods for Inborn Errors of Metabolism Forecast by Application
13 Key Players Analysis
13.1 Nestlé
13.1.1 Nestlé Company Information
13.1.2 Nestlé Medical Foods for Inborn Errors of Metabolism Product Offered
13.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Nestlé Main Business Overview
13.1.5 Nestlé Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Medical Foods for Inborn Errors of Metabolism Product Offered
13.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Reckitt Benckiser Group
13.3.1 Reckitt Benckiser Group Company Information
13.3.2 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Offered
13.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Reckitt Benckiser Group Main Business Overview
13.3.5 Reckitt Benckiser Group Latest Developments
13.4 Ajinomoto
13.4.1 Ajinomoto Company Information
13.4.2 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Offered
13.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ajinomoto Main Business Overview
13.4.5 Ajinomoto Latest Developments
13.5 Solace Nutrition
13.5.1 Solace Nutrition Company Information
13.5.2 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Offered
13.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Solace Nutrition Main Business Overview
13.5.5 Solace Nutrition Latest Developments
13.6 Primus Pharmaceuticals
13.6.1 Primus Pharmaceuticals Company Information
13.6.2 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Offered
13.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Primus Pharmaceuticals Main Business Overview
13.6.5 Primus Pharmaceuticals Latest Developments
13.7 BioMarin Pharmaceutical
13.7.1 BioMarin Pharmaceutical Company Information
13.7.2 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Offered
13.7.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 BioMarin Pharmaceutical Main Business Overview
13.7.5 BioMarin Pharmaceutical Latest Developments
13.8 Danone SA
13.8.1 Danone SA Company Information
13.8.2 Danone SA Medical Foods for Inborn Errors of Metabolism Product Offered
13.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Danone SA Main Business Overview
13.8.5 Danone SA Latest Developments
13.9 Galen Limited
13.9.1 Galen Limited Company Information
13.9.2 Galen Limited Medical Foods for Inborn Errors of Metabolism Product Offered
13.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Galen Limited Main Business Overview
13.9.5 Galen Limited Latest Developments
13.10 PKU-MDMIL
13.10.1 PKU-MDMIL Company Information
13.10.2 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Offered
13.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 PKU-MDMIL Main Business Overview
13.10.5 PKU-MDMIL Latest Developments
14 Research Findings and Conclusion
Table 1. Medical Foods for Inborn Errors of Metabolism Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Medical Foods for Inborn Errors of Metabolism Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Amino Acid
Table 4. Major Players of Glytactin with GMP
Table 5. Major Players of Amino Acid-Modified Infant Formula With Iron
Table 6. Major Players of Low Protein Food
Table 7. Major Players of Others
Table 8. Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 9. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2022)
Table 10. Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2022) & ($ million)
Table 11. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2022)
Table 12. Global Medical Foods for Inborn Errors of Metabolism Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 14. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2022)
Table 15. Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2022)
Table 16. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2022)
Table 17. Global Medical Foods for Inborn Errors of Metabolism Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Medical Foods for Inborn Errors of Metabolism Sales by Company (2020-2022) & (K Units)
Table 19. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Company (2020-2022)
Table 20. Global Medical Foods for Inborn Errors of Metabolism Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Company (2020-2022)
Table 22. Global Medical Foods for Inborn Errors of Metabolism Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Medical Foods for Inborn Errors of Metabolism Producing Area Distribution and Sales Area
Table 24. Players Medical Foods for Inborn Errors of Metabolism Products Offered
Table 25. Medical Foods for Inborn Errors of Metabolism Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Medical Foods for Inborn Errors of Metabolism Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share Geographic Region (2017-2022)
Table 30. Global Medical Foods for Inborn Errors of Metabolism Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Medical Foods for Inborn Errors of Metabolism Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country/Region (2017-2022)
Table 34. Global Medical Foods for Inborn Errors of Metabolism Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022) & (K Units)
Table 37. Americas Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2017-2022)
Table 38. Americas Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2017-2022)
Table 40. Americas Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 41. Americas Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2022)
Table 42. Americas Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 43. Americas Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2022)
Table 44. APAC Medical Foods for Inborn Errors of Metabolism Sales by Region (2017-2022) & (K Units)
Table 45. APAC Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2017-2022)
Table 46. APAC Medical Foods for Inborn Errors of Metabolism Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2017-2022)
Table 48. APAC Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 49. APAC Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2022)
Table 50. APAC Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 51. APAC Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2022)
Table 52. Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022) & (K Units)
Table 53. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2017-2022)
Table 54. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2017-2022)
Table 56. Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 57. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2022)
Table 58. Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 59. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Medical Foods for Inborn Errors of Metabolism
Table 69. Key Market Challenges & Risks of Medical Foods for Inborn Errors of Metabolism
Table 70. Key Industry Trends of Medical Foods for Inborn Errors of Metabolism
Table 71. Medical Foods for Inborn Errors of Metabolism Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Medical Foods for Inborn Errors of Metabolism Distributors List
Table 74. Medical Foods for Inborn Errors of Metabolism Customer List
Table 75. Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Medical Foods for Inborn Errors of Metabolism Sales Market Forecast by Region
Table 77. Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Medical Foods for Inborn Errors of Metabolism Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Medical Foods for Inborn Errors of Metabolism Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Medical Foods for Inborn Errors of Metabolism Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share Forecast by Application (2023-2028)
Table 95. Nestlé Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 96. Nestlé Medical Foods for Inborn Errors of Metabolism Product Offered
Table 97. Nestlé Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Nestlé Main Business
Table 99. Nestlé Latest Developments
Table 100. Abbott Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 101. Abbott Medical Foods for Inborn Errors of Metabolism Product Offered
Table 102. Abbott Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Abbott Main Business
Table 104. Abbott Latest Developments
Table 105. Reckitt Benckiser Group Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 106. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Offered
Table 107. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Reckitt Benckiser Group Main Business
Table 109. Reckitt Benckiser Group Latest Developments
Table 110. Ajinomoto Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 111. Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Offered
Table 112. Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Ajinomoto Main Business
Table 114. Ajinomoto Latest Developments
Table 115. Solace Nutrition Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 116. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Offered
Table 117. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Solace Nutrition Main Business
Table 119. Solace Nutrition Latest Developments
Table 120. Primus Pharmaceuticals Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 121. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Offered
Table 122. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Primus Pharmaceuticals Main Business
Table 124. Primus Pharmaceuticals Latest Developments
Table 125. BioMarin Pharmaceutical Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 126. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Offered
Table 127. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. BioMarin Pharmaceutical Main Business
Table 129. BioMarin Pharmaceutical Latest Developments
Table 130. Danone SA Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 131. Danone SA Medical Foods for Inborn Errors of Metabolism Product Offered
Table 132. Danone SA Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Danone SA Main Business
Table 134. Danone SA Latest Developments
Table 135. Galen Limited Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 136. Galen Limited Medical Foods for Inborn Errors of Metabolism Product Offered
Table 137. Galen Limited Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Galen Limited Main Business
Table 139. Galen Limited Latest Developments
Table 140. PKU-MDMIL Basic Information, Medical Foods for Inborn Errors of Metabolism Manufacturing Base, Sales Area and Its Competitors
Table 141. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Offered
Table 142. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. PKU-MDMIL Main Business
Table 144. PKU-MDMIL Latest Developments
List of Figures
Figure 1. Picture of Medical Foods for Inborn Errors of Metabolism
Figure 2. Medical Foods for Inborn Errors of Metabolism Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Foods for Inborn Errors of Metabolism Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Medical Foods for Inborn Errors of Metabolism Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Amino Acid
Figure 10. Product Picture of Glytactin with GMP
Figure 11. Product Picture of Amino Acid-Modified Infant Formula With Iron
Figure 12. Product Picture of Low Protein Food
Figure 13. Product Picture of Others
Figure 14. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type in 2021
Figure 15. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2022)
Figure 16. Medical Foods for Inborn Errors of Metabolism Consumed in Phenylketonuria (PKU)
Figure 17. Global Medical Foods for Inborn Errors of Metabolism Market: Phenylketonuria (PKU) (2017-2022) & (K Units)
Figure 18. Medical Foods for Inborn Errors of Metabolism Consumed in Maple Syrup Urine Disease (MSUD)
Figure 19. Global Medical Foods for Inborn Errors of Metabolism Market: Maple Syrup Urine Disease (MSUD) (2017-2022) & (K Units)
Figure 20. Medical Foods for Inborn Errors of Metabolism Consumed in Urea Cycle Disorders
Figure 21. Global Medical Foods for Inborn Errors of Metabolism Market: Urea Cycle Disorders (2017-2022) & (K Units)
Figure 22. Medical Foods for Inborn Errors of Metabolism Consumed in Renal Disease
Figure 23. Global Medical Foods for Inborn Errors of Metabolism Market: Renal Disease (2017-2022) & (K Units)
Figure 24. Medical Foods for Inborn Errors of Metabolism Consumed in Others
Figure 25. Global Medical Foods for Inborn Errors of Metabolism Market: Others (2017-2022) & (K Units)
Figure 26. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2022)
Figure 27. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application in 2021
Figure 28. Medical Foods for Inborn Errors of Metabolism Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Company in 2021
Figure 30. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Geographic Region in 2021
Figure 32. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2017-2022)
Figure 33. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country/Region in 2021
Figure 34. Americas Medical Foods for Inborn Errors of Metabolism Sales 2017-2022 (K Units)
Figure 35. Americas Medical Foods for Inborn Errors of Metabolism Revenue 2017-2022 ($ Millions)
Figure 36. APAC Medical Foods for Inborn Errors of Metabolism Sales 2017-2022 (K Units)
Figure 37. APAC Medical Foods for Inborn Errors of Metabolism Revenue 2017-2022 ($ Millions)
Figure 38. Europe Medical Foods for Inborn Errors of Metabolism Sales 2017-2022 (K Units)
Figure 39. Europe Medical Foods for Inborn Errors of Metabolism Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales 2017-2022 (K Units)
Figure 41. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue 2017-2022 ($ Millions)
Figure 42. Americas Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country in 2021
Figure 43. Americas Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country in 2021
Figure 44. United States Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region in 2021
Figure 49. APAC Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Regions in 2021
Figure 50. China Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country in 2021
Figure 57. Europe Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country in 2021
Figure 58. Germany Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country in 2021
Figure 65. Egypt Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Medical Foods for Inborn Errors of Metabolism Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Medical Foods for Inborn Errors of Metabolism in 2021
Figure 71. Manufacturing Process Analysis of Medical Foods for Inborn Errors of Metabolism
Figure 72. Industry Chain Structure of Medical Foods for Inborn Errors of Metabolism
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...